z8 Health is a revenue cycle consulting and workflow solutions firm for mid-size practices and PE-backed healthcare companies. We bring enterprise-level operational expertise and practical technology guidance to organizations that need senior strategic capacity, without the overhead of a permanent hire.
z8 Health is a revenue cycle management consulting and workflow solutions firm founded by credentialed RCM leadership with two decades of experience driving revenue cycle transformation across multi-specialty organizations, MSOs, and high-growth healthcare companies.
Our team operates at the intersection of deep operational expertise and technology-informed problem solving. We bring the same analytical rigor and strategic discipline that large health systems invest significant resources in, structured to be accessible to organizations that are scaling, stabilizing, or navigating complexity without a full executive bench to draw from.
We work nationally. Engagements are structured project-based, retainer, or fractional, matched to the actual scope of the problem.
We work with organizations that are past the deal but not yet at scale: running multiple sites, managing fragmented revenue cycle infrastructure, and building an RCM function that performs consistently without a fully staffed executive team. Our engagements are national, remote-first, and structured around the actual scope of the problem.
You're running RCM across multiple sites with fragmented PM systems, inconsistent denial categorization, and a PE sponsor asking for a unified KPI dashboard that doesn't exist yet. You need an outside partner who has operated inside this environment, not a consulting firm that needs six weeks to understand your problem.
You own the P&L but not the RCM operation. Revenue is trailing the acquisition thesis and you can't get a clean read on whether it's a volume problem or an RCM problem. Your Director of RCM runs billing well but lacks the strategic bandwidth to build the function at platform scale. You need VP-level thinking without making a permanent hire before you know what the role should look like.
We don't sell shelfware or ten-month assessments. Every engagement is built to deliver a measurable financial or operational outcome, leaving your team better equipped to sustain it.
End-to-end revenue cycle assessments, denial and AR diagnostics, payer strategy, and operational design for organizations preparing to scale, integrate acquisitions, or remediate underperforming revenue cycle infrastructure.
Fractional engagements also available
Interim leadership means z8 Health takes the seat. We step into a full-time, defined-scope role, own the RCM strategy layer, and carry accountability for outcomes through a transition or buildout period. The engagement ends when your organization is ready for a permanent hire - or when we have helped you define and fill that role. Fractional leadership is a different structure: part-time, retainer-based, and designed for organizations that need ongoing senior RCM access without a full-time executive footprint. Both models are available; the right one depends on where you are in your growth cycle.
Better outcomes don’t always require new software, but when technology is the answer, the wrong choice is expensive. We design the workflows first, then identify whether automation or AI tools are the right lever and which vendors can deliver. We connect clients with vetted solutions and stay engaged to ensure the build matches the operational reality.
For organizations navigating denial management complexity, prior authorization burdens, and the accelerating pace of payer policy change, the right technology decision starts with knowing your process. We help you understand what you actually need before you commit to how to get there.
We analyze and redesign revenue cycle workflows before recommending any tool. Technology built on a broken process is just a faster way to produce the same wrong result.
We don’t sell software. Our recommendations are based on what fits your operation, your team, and your budget, with no vendor relationship or implementation fee behind the recommendation.
We’ve run revenue cycle operations. When we evaluate a technology platform, we read it through the lens of the people who will actually use it, not a product demo.
Short-form analysis on revenue cycle, regulatory shifts, and the operational realities of scaling RCM in mid-size healthcare organizations. New posts on LinkedIn.
ERISA preempts the state specialty-matching statutes that most providers rely on in peer-to-peer reviews, leaving 60% of commercially insured patients outside their reach. Part 5 maps what the federal framework actually provides, where contract language can fill the gap, and what to do when neither option applies.
Seven states require the physician reviewing your denial to hold the same or similar specialty as your treating provider. Two produced enforcement actions in 2025 totaling $725,000 in fines. Part 4 of the Unappealed Denial Series covers what the law requires, what regulators found, and what your team should be doing on every peer-to-peer call.
The appeal you didn't file is the most expensive decision in your denial management operation. Here's the workflow that changes that default.
Payers like UnitedHealthcare don't deny claims because the system is broken; they deny them because it works. This article breaks down how systematic denial of unworked claims functions as a payer cash flow strategy, and what RCM teams can do about it.
When a denial gets written off instead of worked, it doesn’t disappear; it becomes a pattern. Part one of a series on the write-off decisions quietly draining your net revenue.
What happens when AI handles the conversations your team used to have - and why the trust gap it creates is a revenue cycle problem, not just a culture one.
Why the biggest barrier to AI in revenue cycle isn't the technology, covering the six organizational commitments PE-backed practices keep skipping before they flip the switch.
Why PE-backed specialty platforms are flying blind through performance years, along with a four-part assessment that changes that.
What the regulatory direction signals for revenue cycle leaders, and why operationalizing it is going to take more than policy compliance.
Rethinking appeals strategy when payer review processes are increasingly automated, and what that means for the data you put in front of them.